Chemical Structure : Tralokinumab
CAS No.: 1044515-88-9
货号: PC-Ab1054Not For Human Use, Lab Use Only.
Tralokinumab (CAT-354) is an potent and selective IL-13-neutralizing IgG4 monoclonal antibody (mAb). Tralokinumab specifically binds with high affinity to IL-13, inhibiting its interaction with the IL-13 receptor and thereby neutralising the biological activity of the cytokine. Tralokinumab was approved for the treatment of moderate-to-severe atopic dermatitis..
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥3580 | In stock | |
| 5 mg | ¥7580 | In stock | |
| 10 mg | ¥12800 | In stock | |
| 100 mg | Get quote | 
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Tralokinumab (CAT-354) is an potent and selective IL-13-neutralizing IgG4 monoclonal antibody (mAb). Tralokinumab specifically binds with high affinity to IL-13, inhibiting its interaction with the IL-13 receptor and thereby neutralising the biological activity of the cytokine. Tralokinumab was approved for the treatment of moderate-to-severe atopic dermatitis.
| 分子量 | ||
| 分子式 | Human IgG4P-Kappa | |
| 外观性状 | Solid | |
| 储存条件 | 
                            
  | 
                        
                            
  | 
                    
| Solubility | 
                             PBS, pH 7.0 Contains no stabilizers or preservatives  | 
                    |
| Chemical Name/SMILES | 
                             Tralokinumab; Adtralza; 1044515-88-9; CAT-354; LP 0162; Interleukin 13 signaling; IL-13 antibody  | 
                    |
1. 1, Antohe I, et al. Expert Opin Biol Ther. 2013 Feb;13(2):323-6. 2, Walsh GM. Curr Opin Investig Drugs. 2010 Nov;11(11):1305-12. 3, Murray LA, et al. Am J Respir Cell Mol Biol. 2014 May;50(5):985-94. 4, May RD, et al. Br J Pharmacol. 2012 May;166(1):177-93.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright